Neostigmine Flashcards
Class
reversal, anticholinesterase
structure
quanternary ammonia
does not cross bbb
mech of action
covalently binds to the carbamyl group of the acetylcholinesterases, inhibiting the breakdown of AcH in the NMJ and increases the availability of ACh at the motor end plate
PB
LS
VD
PB low
LS low
VD: 1L/kg
elimination
plasma and liver esterases and excreted 50% unchanged in urine
active metabolite
3-hydroxyphenyltrimethylammonium
1/10th as potent
side effects
decrease SVR, BP, HR
bronchoconstriction
increase saliva
increase gastric secretion
seizures
contraindications
renal failure: increased doa
GI/GU obstruction
asthma
use with caution in CAD
dose
0.04 - 0.07 mg/kg
administrate with glyco 0.01 mg/kg
onset
DOA
T1/2
onset: 3-5 min
DOA: 1 hr
T1/2: 70-80 min